CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products
CBD Life Sciences Inc. (OTC PINK:CBDL) announces its expansion strategy targeting Alibaba, the world's largest retail and e-commerce platform. This move aims to offer CBDL's top-selling CBD products to Alibaba's wholesale marketplace, accessing over 1.28 billion annual active consumers and $3 trillion in gross merchandise volume. The expansion is expected to drive exponential revenue growth and global market penetration.
CBDL's entry into Alibaba's platform, which facilitates over $172 billion in cross-border commerce annually, presents an opportunity to capitalize on the growing demand for CBD products globally. The company's flagship products will be available to wholesalers across Asia, Europe, and beyond. This expansion follows CBDL's impressive 1405.46% revenue increase since February 2024 and aligns with the projected growth of the global CBD market, expected to exceed $47 billion by 2028.
CBD Life Sciences Inc. (OTC PINK:CBDL) annuncia la sua strategia di espansione mirata a Alibaba, la più grande piattaforma di retail e e-commerce al mondo. Questa mossa mira a offrire i prodotti CBD più venduti da CBDL nel mercato all'ingrosso di Alibaba, accedendo a oltre 1,28 miliardi di consumatori attivi annuali e 3 trilioni di dollari in volume lordo delle merci. Si prevede che l'espansione generi una crescita esponenziale dei ricavi e una penetrazione nel mercato globale.
L'ingresso di CBDL nella piattaforma di Alibaba, che facilita oltre 172 miliardi di dollari nel commercio transfrontaliero ogni anno, rappresenta un'opportunità per capitalizzare sulla crescente domanda di prodotti CBD a livello globale. I prodotti di punta dell'azienda saranno disponibili per i grossisti in Asia, Europa e oltre. Questa espansione segue un'impressionante aumento del 1405,46% dei ricavi da febbraio 2024 e si allinea con la crescita prevista del mercato globale del CBD, che dovrebbe superare 47 miliardi di dollari entro il 2028.
CBD Life Sciences Inc. (OTC PINK:CBDL) anuncia su estrategia de expansión enfocada en Alibaba, la plataforma de venta al por menor y comercio electrónico más grande del mundo. Este movimiento tiene como objetivo ofrecer los productos CBD más vendidos de CBDL en el mercado mayorista de Alibaba, accediendo a más de 1.28 mil millones de consumidores activos anuales y 3 billones de dólares en volumen bruto de mercancías. Se espera que la expansión impulse un crecimiento exponencial de los ingresos y la penetración en el mercado global.
La entrada de CBDL en la plataforma de Alibaba, que facilita más de 172 mil millones de dólares en comercio transfronterizo al año, presenta una oportunidad para capitalizar la creciente demanda de productos CBD a nivel global. Los productos insignia de la empresa estarán disponibles para mayoristas en Asia, Europa y más allá. Esta expansión sigue a un impresionante incremento del 1405.46% en los ingresos desde febrero de 2024 y está alineada con el crecimiento proyectado del mercado global de CBD, que se espera que supere 47 mil millones de dólares para 2028.
CBD Life Sciences Inc. (OTC PINK:CBDL)는 세계 최대의 소매 및 전자상거래 플랫폼인 알리바바를 목표로 하는 확장 전략을 발표했습니다. 이 조치는 CBDL의 베스트셀러 CBD 제품을 알리바바의 도매 시장에 제공하는 것을 목표로 하고 있으며, 12억 8천만 명의 연간 활성 소비자와 3조 달러의 총 상품 거래량에 접근하는 것입니다. 이번 확장은 기하급수적인 수익 성장과 글로벌 시장 침투를 이끌 것으로 예상됩니다.
알리바바 플랫폼에 진입하는 CBDL은 매년 1720억 달러 이상의 국경 간 거래를 촉진하며, 전 세계적으로 증가하는 CBD 제품 수요를 활용할 기회를 제공합니다. 이 회사의 주력 제품은 아시아, 유럽 등에서 도매업체들에게 제공될 예정입니다. 이번 확장은 2024년 2월 이후 1405.46%의 수익 증가를 이뤄낸 CBDL의 성장을 바탕으로 하며, 2028년까지 470억 달러를 초과할 것으로 예상되는 글로벌 CBD 시장의 성장과 맞물려 있습니다.
CBD Life Sciences Inc. (OTC PINK:CBDL) annonce sa stratégie d'expansion visant Alibaba, la plus grande plateforme de vente au détail et de commerce électronique au monde. Ce mouvement vise à offrir les produits CBD les plus vendus de CBDL sur le marché de gros d'Alibaba, accédant à plus de 1,28 milliard de consommateurs actifs annuels et 3 billions de dollars en volume brut de marchandises. L'expansion devrait générer une croissance exponentielle des revenus et une pénétration du marché mondial.
L'entrée de CBDL sur la plateforme d'Alibaba, qui facilite plus de 172 milliards de dollars de commerce transfrontalier chaque année, représente une opportunité de capitaliser sur la demande croissante de produits CBD à l'échelle mondiale. Les produits phares de l'entreprise seront disponibles pour les grossistes en Asie, en Europe et au-delà. Cette expansion fait suite à une impressionnante augmentation de 1405,46 % des revenus depuis février 2024 et s'aligne sur la croissance projetée du marché mondial du CBD, qui devrait dépasser 47 milliards de dollars d'ici 2028.
CBD Life Sciences Inc. (OTC PINK:CBDL) kündigt seine Expansionsstrategie an, die sich auf Alibaba, die größte Einzelhandels- und E-Commerce-Plattform der Welt, konzentriert. Dieser Schritt zielt darauf ab, die meistverkauften CBD-Produkte von CBDL auf dem Großhandelsmarkt von Alibaba anzubieten, was Zugang zu über 1,28 Milliarden jährlich aktiven Verbrauchern und 3 Billionen Dollar an Bruttowarenumsatz ermöglicht. Es wird erwartet, dass die Expansion exponentielles Umsatzwachstum und globale Marktdurchdringung vorantreibt.
Der Eintritt von CBDL auf die Plattform von Alibaba, die jährlich über 172 Milliarden Dollar im grenzüberschreitenden Handel erleichtert, bietet die Möglichkeit, von der wachsenden Nachfrage nach CBD-Produkten weltweit zu profitieren. Die Hauptprodukte des Unternehmens werden Großhändlern in Asien, Europa und darüber hinaus zur Verfügung stehen. Diese Expansion folgt einem beeindruckenden Umsatzanstieg von 1405,46% seit Februar 2024 und steht im Einklang mit dem erwarteten Wachstum des globalen CBD-Marktes, das bis 2028 47 Milliarden Dollar überschreiten soll.
- Expansion into Alibaba's platform, accessing 1.28 billion annual active consumers and $3 trillion in gross merchandise volume
- 1405.46% revenue increase since February 2024
- Access to Alibaba's $172 billion annual cross-border commerce
- Potential for exponential revenue growth and global market penetration
- Alignment with projected growth of global CBD market, expected to exceed $47 billion by 2028
- None.
Leveraging Alibaba's 1.28 billion annual active consumers and
SCOTTSDALE, AZ / ACCESSWIRE / October 10, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a trailblazer in the CBD industry, proudly announces a bold new step in its expansion strategy by targeting Alibaba, the world's largest retail and e-commerce platform. With an eye on global dominance, CBDL is set to offer its top-selling CBD products to Alibaba's vast wholesale marketplace, unlocking access to over 1.28 billion annual active consumers and an astounding
"Our entrance into Alibaba is more than just an expansion-it's a game-changer," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "Alibaba's platform opens up access to markets we've only just begun to explore, and this leap forward will not only drive our revenue to new heights but will strengthen our relationship with valued shareholders, who are the backbone of our success."
Massive Opportunity: Alibaba's Wholesale Powerhouse
Alibaba is the world's top e-commerce platform, facilitating over
By tapping into Alibaba's extensive network of buyers, CBD Life Sciences is positioning itself as a leading supplier of CBD products to retailers around the globe. This expansion is expected to amplify both domestic and international sales, contributing to the already
Unstoppable Growth and Shareholder Confidence
Since early 2024, CBD Life Sciences has maintained an impressive upward trajectory, breaking records quarter after quarter. Shareholders have witnessed the company's evolution from a pioneering CBD startup to an industry leader with a diverse product line that caters to a growing market of health-conscious consumers. This expansion into Alibaba ensures that CBDL will not only maintain but accelerate this momentum.
As the global CBD market continues to surge-expected to exceed
"With our entrance into Alibaba, we're taking the brand global at a scale we've never seen before. Our loyal shareholders are at the heart of this growth, and their support allows us to keep pushing boundaries, explore new opportunities, and bring cutting-edge products to consumers worldwide," added Nelson. "Together, we will conquer new markets and achieve new heights."
Looking Ahead: Unwavering Commitment to Innovation and Expansion
CBD Life Sciences Inc. remains committed to providing best-in-class CBD products, with a portfolio ranging from water-soluble nano CBD formulations to CBD pain relief solutions that continue to set industry standards. The company is also focused on future innovations, with new product launches expected in the upcoming quarters, all designed to deliver unrivaled quality and efficacy.
By leveraging Alibaba's vast wholesale distribution channels, CBD Life Sciences is laying the groundwork for long-term growth and sustainability. Shareholders can expect sustained success, as the company continues to execute on its aggressive global expansion strategy. Every step forward is an opportunity to deliver value and drive substantial returns for those who have invested in the company's vision.
About CBD Life Sciences Inc.
CBD Life Sciences Inc. (OTC: CBDL) is a leader in the CBD sector, specializing in innovative, high-quality products that utilize cutting-edge nanotechnology for superior bioavailability and maximum health benefits. With a broad portfolio of products, from pain creams to consumables, CBDL is committed to enhancing the lives of its consumers. The company is on a fast-paced trajectory to expand its global presence through retail and wholesale channels, both online and in brick-and-mortar stores.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information:
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
Related Images
|
SOURCE: CBD Life Sciences Inc.
View the original press release on accesswire.com
FAQ
What is CBD Life Sciences Inc.'s (CBDL) new expansion strategy?
How many active consumers does Alibaba have, and what is its gross merchandise volume?
What revenue increase has CBDL experienced since February 2024?
What is the projected value of the global CBD market by 2028?
How much cross-border commerce does Alibaba facilitate annually?
